Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Elexir Pharma AB
AB
Active
Org 5568544026
Kornhamnstorg 61, 111 27
Stockholm
Wholesale of other food
· NACE 4638
Est. 2011
20-49 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of other food
/
Elexir Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
39M
78M
116M
155M
67M
2020
81M
2021
87M
2022
108M
2023
135M
2024
EBITDA
SEK millions
0M
5M
10M
16M
21M
18M
2020
13M
2021
12M
2022
12M
2023
16M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
67 399
81 156
87 081
107 534
135 004
Staff expenses
—
—
—
—
—
EBITDA
17 746
12 687
12 175
12 380
15 803
Depreciation & amort.
−437
−328
−139
−159
−139
EBIT
17 309
12 359
12 036
12 221
15 664
Net financials
−6
−6
−88
26
47
Profit before tax
13 269
12 352
11 994
12 697
15 711
Tax
−2 873
−2 695
−2 552
−2 785
−3 252
Net profit
10 396
9 657
9 442
9 912
12 459
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
31 947
30 450
34 987
45 371
60 801
Equity
13 008
14 840
19 290
26 190
33 628
Long-term debt
1 066
1 030
−415
70
57
Short-term debt
11 373
8 081
9 611
13 111
21 117
Total debt
12 439
9 111
9 196
13 181
21 174
Financial ratios
5-year trend
EBITDA margin
11.7%
This company
15.8%
Market median
-26% vs market
2020
2024
Equity ratio
55.3%
This company
38.2%
Market median
+45% vs market
2020
2024
Return on equity
37.0%
This company
18.4%
Market median
+101% vs market
2020
2024
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
2020
2024
Asset turnover
2.22×
This company
1.12×
Market median
+98% vs market
2020
2024
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Elexir Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
